Creatinine Measurement Market Forecasts to 2028 – Global Analysis By Product (Reagents, Kits), Test Type (Enzymatic, Jaffe’s Kinetic), Sample (Blood/Serum, Urine), End User (Diagnostic Laboratories, Hospitals) and By Geography
According to Stratistics MRC, the Global Creatinine Measurement Market is accounted for $421.24 million in 2020 and is expected to reach $909.56 million by 2028 growing at a CAGR of 10.1% during the forecast period. The increasing renal functioning disorder and rising geriatric population are driving the market. However, often changing regulatory policies and recognition of novel renal dysfunction biomarkers are hampering the market growth.
Creatinine measurement is the process of measuring creatinine. Creatinine is a waste product that is obtained from the human body due to the general breakdown of muscle tissues. The creatinine produced in the body is then filtered using kidneys. The basic kidney test carried out is analyzed using the creatinine levels in the blood.
Based on the sample, the blood/serum segment is estimated to have a lucrative growth due to accurateness in inferring creatinine concentration and less menace of contamination. These benefits are liable for the growing acceptance of the blood/serum sample for the measurement of creatinine levels.
By geography, North America holds the largest market share owing to the factors such as the rising occurrence of renal disorders, increasing the prevalence of other chronic disorders like hypertension and diabetes, and the implementation of favorable management initiatives to raise awareness about kidney diseases and the untimely diagnosis.
Some of the key players profiled in the Creatinine Measurement Market include Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Ortho Clinical Diagnostics, Diazyme Laboratories, Inc, Dialab GmbH, and Sentinel Ch. SPA, Diasys Diagnostic Systems GmbH, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc., Randox Laboratories, Wako Pure Chemical Industries, Ltd, Abcam Plc, Siemens Healthineers AG, and Abbexa Ltd.
Estimated Market Size in 2020:
USD 421.24 million
Compound Annual Growth Rate (CAGR) from 2020 to 2028:
Predicted 2028 Value:
USD 909.56 million
Tables, Graphs & Figures
Product, Test Type, Sample, End User and Region
Core Drivers and Opportunities:
Restraining Factors & Market Threats:
Test Types Covered:
• Enzymatic Method
• Jaffe’s Kinetic Method
End Users Covered:
• Diagnostic Laboratories
• Hospitals & Clinics
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Key Questions Answered In The Report
The Global Creatinine Measurement Market is majorly driven by the growing renal functioning disorder and rising geriatric population.
The reagents segment is growing at the highest CAGR due to the low cost and easy accessibility of reagents.
North America dominated with a significant market share due to the rising prevalence of kidney disorders and the high availability of well-developed healthcare infrastructure.
Asia Pacific market is growing at the highest CAGR due to the growing adoption of advanced diagnostic testing and rapid expansion of health care infrastructure.
Key players in Creatinine Measurement Market include Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Ortho Clinical Diagnostics, Diazyme Laboratories, Inc, Dialab GmbH, and Sentinel Ch. SPA, Diasys Diagnostic Systems GmbH, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc., Randox Laboratories, Wako Pure Chemical Industries, Ltd, Abcam Plc, Siemens Healthineers AG, and Abbexa Ltd.
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.